About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Once-A-Day Pregabalin For Partial Seizures

NCT01262677·82 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Diagnosis of epilepsy with partial onset seizures (seizures may be simple or complex, with or without evolution into a bilateral, convulsive seizure)
Currently taking 1 to 3 anti-epilepsy medicines (AEDs) at stable dosages, and who have taken at least 2 prior (or ongoing) AEDs

You may not be if

Primary generalized seizures (for example, absence, myoclonic seizures or Lennox-Gastaut Syndrome)
Status epilepticus within one year prior to screening

The record

StatusCompleted

PhasePhase 3

Taking part325

StartedFeb 2011

UpdatedJan 25, 2021

Conditions

Partial Seizures Epilepsies, Partial

Where82

Neurology Clinic, PC
Northport, Alabama, United States
NEA Baptist Clinic
Jonesboro, Arkansas, United States
Clinical Trials, Inc.
Little Rock, Arkansas, United States

Clareo Health | Once-A-Day Pregabalin For Partial Seizures